apomorphine
Genito-urinary system and sex hormones (G04)Genito-urinary system and sex hormones (G04) compound in Serina Therapeutics's portfolio. Mechanism: D2-like dopamine receptor agonist.
- Mechanism
- D2-like dopamine receptor agonist
pharma · Parkinson's Disease · PARKINSON DISEASE (Disorder) · SER
Serina Therapeutics
Serina Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Huntsville, USA HQ
2007 Founded
23 Employees
Public company Type
SER · NYSE Ticker
Company details
- Status
- Public
- HQ
- Huntsville, USA
- Founded
- 2007
- Employees
- 23
- Programs
- 2
- Drugs
- 3
- Patents
- 25
Serina Therapeutics pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Serina Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Serina Therapeutics in public FDA and regional records.
-
Development asset linked to Serina Therapeutics in public FDA and regional records. Mechanism: Mu opioid receptor agonist.
- Mechanism
- Mu opioid receptor agonist